S&P 500   3,373.84 (+1.20%)
DOW   27,866.88 (+0.65%)
QQQ   271.60 (+2.42%)
AAPL   451.26 (+3.15%)
MSFT   208.98 (+2.75%)
FB   260.14 (+1.57%)
GOOGL   1,504.61 (+1.63%)
AMZN   3,153.53 (+2.37%)
NVDA   454.90 (+4.82%)
CGC   17.43 (+2.83%)
BABA   255.34 (+2.79%)
TSLA   1,521.05 (+10.67%)
GE   6.60 (-1.93%)
MU   48.28 (+1.09%)
AMD   82.01 (+6.67%)
T   30.14 (-0.20%)
F   7.07 (-2.21%)
ACB   9.92 (-1.00%)
GILD   68.85 (+1.10%)
NFLX   479.22 (+2.63%)
DIS   130.80 (+0.24%)
BAC   26.49 (-1.60%)
BA   173.97 (-3.42%)
S&P 500   3,373.84 (+1.20%)
DOW   27,866.88 (+0.65%)
QQQ   271.60 (+2.42%)
AAPL   451.26 (+3.15%)
MSFT   208.98 (+2.75%)
FB   260.14 (+1.57%)
GOOGL   1,504.61 (+1.63%)
AMZN   3,153.53 (+2.37%)
NVDA   454.90 (+4.82%)
CGC   17.43 (+2.83%)
BABA   255.34 (+2.79%)
TSLA   1,521.05 (+10.67%)
GE   6.60 (-1.93%)
MU   48.28 (+1.09%)
AMD   82.01 (+6.67%)
T   30.14 (-0.20%)
F   7.07 (-2.21%)
ACB   9.92 (-1.00%)
GILD   68.85 (+1.10%)
NFLX   479.22 (+2.63%)
DIS   130.80 (+0.24%)
BAC   26.49 (-1.60%)
BA   173.97 (-3.42%)
S&P 500   3,373.84 (+1.20%)
DOW   27,866.88 (+0.65%)
QQQ   271.60 (+2.42%)
AAPL   451.26 (+3.15%)
MSFT   208.98 (+2.75%)
FB   260.14 (+1.57%)
GOOGL   1,504.61 (+1.63%)
AMZN   3,153.53 (+2.37%)
NVDA   454.90 (+4.82%)
CGC   17.43 (+2.83%)
BABA   255.34 (+2.79%)
TSLA   1,521.05 (+10.67%)
GE   6.60 (-1.93%)
MU   48.28 (+1.09%)
AMD   82.01 (+6.67%)
T   30.14 (-0.20%)
F   7.07 (-2.21%)
ACB   9.92 (-1.00%)
GILD   68.85 (+1.10%)
NFLX   479.22 (+2.63%)
DIS   130.80 (+0.24%)
BAC   26.49 (-1.60%)
BA   173.97 (-3.42%)
S&P 500   3,373.84 (+1.20%)
DOW   27,866.88 (+0.65%)
QQQ   271.60 (+2.42%)
AAPL   451.26 (+3.15%)
MSFT   208.98 (+2.75%)
FB   260.14 (+1.57%)
GOOGL   1,504.61 (+1.63%)
AMZN   3,153.53 (+2.37%)
NVDA   454.90 (+4.82%)
CGC   17.43 (+2.83%)
BABA   255.34 (+2.79%)
TSLA   1,521.05 (+10.67%)
GE   6.60 (-1.93%)
MU   48.28 (+1.09%)
AMD   82.01 (+6.67%)
T   30.14 (-0.20%)
F   7.07 (-2.21%)
ACB   9.92 (-1.00%)
GILD   68.85 (+1.10%)
NFLX   479.22 (+2.63%)
DIS   130.80 (+0.24%)
BAC   26.49 (-1.60%)
BA   173.97 (-3.42%)
Log in

NASDAQ:AMEHApollo Medical Stock Price, Forecast & News

$17.95
+0.32 (+1.82 %)
(As of 08/12/2020 01:24 PM ET)
Add
Compare
Today's Range
$17.73
Now: $17.95
$17.99
50-Day Range
$15.53
MA: $16.61
$17.77
52-Week Range
$9.27
Now: $17.95
$23.26
Volume487 shs
Average Volume54,939 shs
Market Capitalization$952.79 million
P/E Ratio30.95
Dividend YieldN/A
Beta0.4
Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. was founded in 1994 and is headquartered in Alhambra, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.82 out of 5 stars


Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AMEH
CUSIPN/A
Phone626-282-0288

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$560.62 million
Cash Flow$1.05 per share
Book Value$5.51 per share

Profitability

Net Income$14.12 million

Miscellaneous

Employees475
Market Cap$952.79 million
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
$17.95
+0.32 (+1.82 %)
(As of 08/12/2020 01:24 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AMEH News and Ratings via Email

Sign-up to receive the latest news and ratings for AMEH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Apollo Medical (NASDAQ:AMEH) Frequently Asked Questions

How has Apollo Medical's stock been impacted by COVID-19 (Coronavirus)?

Apollo Medical's stock was trading at $14.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AMEH shares have increased by 27.6% and is now trading at $17.95.
View which stocks have been most impacted by Coronavirus
.

When is Apollo Medical's next earnings date?

Apollo Medical is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Apollo Medical
.

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings Inc (NASDAQ:AMEH) announced its earnings results on Wednesday, May, 27th. The company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.07. The company had revenue of $165.11 million for the quarter. Apollo Medical had a net margin of 3.24% and a return on equity of 11.90%.
View Apollo Medical's earnings history
.

Has Apollo Medical been receiving favorable news coverage?

Headlines about AMEH stock have trended negative on Wednesday, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Apollo Medical earned a news impact score of -2.2 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next few days.
View the latest news about Apollo Medical
.

Are investors shorting Apollo Medical?

Apollo Medical saw a decrease in short interest in July. As of July 31st, there was short interest totaling 492,800 shares, a decrease of 10.2% from the July 15th total of 548,900 shares. Based on an average daily volume of 80,700 shares, the days-to-cover ratio is presently 6.1 days. Approximately 2.7% of the shares of the stock are short sold.
View Apollo Medical's Short Interest
.

Who are some of Apollo Medical's key competitors?

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include SEA (SE), Paypal (PYPL), Gilead Sciences (GILD), Bristol-Myers Squibb (BMY), Exxon Mobil (XOM), Alibaba Group (BABA), Walt Disney (DIS), DexCom (DXCM), Energy Transfer LP Unit (ET) and General Electric (GE).

Who are Apollo Medical's key executives?

Apollo Medical's management team includes the following people:
  • Dr. Kenneth T. Sim M.D., Exec. Chairman
  • Dr. Thomas S. Lam, CEO & Director (Age 70)
  • Mr. Eric Chin, Chief Financial Officer
  • Mr. Hing Ang, Chief Operating Officer
  • Dr. Albert Young M.D., Co-Chief Medical Officer

What is Apollo Medical's stock symbol?

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Who are Apollo Medical's major shareholders?

Apollo Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Swiss National Bank (0.12%), Manchester Financial Inc. (0.10%), WINTON GROUP Ltd (0.06%), California Public Employees Retirement System (0.04%), Virtu Financial LLC (0.02%) and New York State Common Retirement Fund (0.02%). Company insiders that own Apollo Medical stock include Adrian Vazquez, Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied, Thomas S Lam and Warren Hosseinion.
View institutional ownership trends for Apollo Medical
.

Which major investors are selling Apollo Medical stock?

AMEH stock was sold by a variety of institutional investors in the last quarter, including Manchester Financial Inc., and UBS Group AG.
View insider buying and selling activity for Apollo Medical
.

Which major investors are buying Apollo Medical stock?

AMEH stock was acquired by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Swiss National Bank, Virtu Financial LLC, New York State Common Retirement Fund, and WINTON GROUP Ltd. Company insiders that have bought Apollo Medical stock in the last two years include Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied, and Thomas S Lam.
View insider buying and selling activity for Apollo Medical
.

How do I buy shares of Apollo Medical?

Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Apollo Medical's stock price today?

One share of AMEH stock can currently be purchased for approximately $17.95.

How big of a company is Apollo Medical?

Apollo Medical has a market capitalization of $952.79 million and generates $560.62 million in revenue each year. The company earns $14.12 million in net income (profit) each year or $0.43 on an earnings per share basis. Apollo Medical employs 475 workers across the globe.

What is Apollo Medical's official website?

The official website for Apollo Medical is www.apollomed.net.

How can I contact Apollo Medical?

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The company can be reached via phone at 626-282-0288 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.